Reversible hypohidrosis with topiramate therapy for chronic migraine

Headache

Volumn 50, Issue 4, 2010, Pages 672-674

  Markowitz, Shira Y ^a   Robbins, Matthew S ^a   Cascella, Clair ^a   Sheikh, Huma U ^a   Grosberg, Brian M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Adult; Hypohidrosis; Migraine; Topiramate

Indexed keywords

ANTIMIGRAINE AGENT; PARACETAMOL; TOPIRAMATE;

ABSENCE OF SIDE EFFECTS; ADULT; ANAMNESIS; ANHIDROSIS; ARTICLE; CASE REPORT; CHRONIC DISEASE; CLINICAL FEATURE; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG OVERDOSE; FEVER; HUMAN; MALE; MIGRAINE; PRIORITY JOURNAL; REHYDRATION; TREATMENT RESPONSE;

ADULT; ANTICONVULSANTS; FEVER; FLUID THERAPY; FRUCTOSE; HEADACHE DISORDERS; HOT TEMPERATURE; HUMANS; HYPERTENSION; HYPOHIDROSIS; INFUSIONS, INTRAVENOUS; MALE; MIGRAINE DISORDERS; OBESITY, MORBID; PATIENT EDUCATION AS TOPIC; SLEEP APNEA SYNDROMES; SWEAT GLANDS; SWEATING; TREATMENT OUTCOME;

EID: 77950533722     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2010.01636.x     Document Type: Article

References (15)

1. Margari L, Ventura P, Buttiglione M, et al. Electrophysiological study in 2 children with transient hypohidrosis induced by topiramate. Clin Neuropharmacol. 2008 31 : 339 346.
2. Incecik F, Hergüner MO, Altunbasak S. Topiramate associated hypohidrosis and hyperthermia. Indian Pediatr. 2008 45 : 238 240.
3. Fung EL, Nelson EA. Oligohydrosis underestimated side effect with topiramate treatment. Indian J Pediatr. 2007 74 : 694.
4. Cerminara C, Seri S, Bombardieri R, Pinci M, Curatolo P. Hypohidrosis during topiramate treatment: A rare and reversible side effect. Pediatr Neurol. 2006 34 : 392 394.
5. Ben-Zeev B, Watemberg N, Augarten A, et al. Oligohydrosis and hyperthermia: Pilot study of a novel topiramate adverse effect. J Child Neurol. 2003 18 : 254 257.
6. Arcas J, Ferrer T, Roche MC, Martínez-Bermejo A, López-Martín V. Hypohidrosis related to the administration of topiramate to children. Epilepsia. 2001 42 : 1363 1365.
7. de Carolis P, Magnifico F, Pierangeli G, et al. Transient hypohidrosis induced by topiramate. Epilepsia. 2003 44 : 974 976.
8. Galicia SC, Lewis SL, Metman LV. Severe topiramate-associated hyperthermia resulting in persistent neurological dysfunction. Clin Neuropharmacol. 2005 28 : 94 95.
9. Limmroth V, Biondi D, Pfeil J, Schwalen S. Topiramate in patients with episodic migraine: Reducing the risk for chronic forms of headache. Headache. 2007 47 : 13 21.
10. Silberstein SD, Lipton RB, Dodick DW, et al. Topiramate Chronic Migraine Study Group. Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized, double-blind, placebo-controlled trial. Headache. 2007 47 : 170 180.
11. Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ TOPMAT-MIG-201(TOP-CHROME) Study Group. Topiramate reduces headache days in chronic migraine: A randomized, double-blind, placebo-controlled study. Cephalalgia. 2007 27 : 814 823.
12. Blaise FD. Bourgeois, pharmacokinetics and pharmacodynamics of topiramate. J Child Neurol. 2000 15 : S27.
13. Welch BJ, Graybeal D, Moe OW, Maalouf NM, Sakhaee K. Biochemical and stone-risk profiles with topiramate treatment. Am J Kidney Dis. 2006 48 : 555 563.
14. Dodgson SJ, Shank RP, Maryanoff BE. Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilespia. 2000 41 (Suppl. I S35 S39.
15. Ma L, Huang YG, Deng YC, et al. Topiramate reduced sweat secretion and aquaporin-5 expression in sweat glands of mice. Life Sci. 2007 80 : 2461 2468.